News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
PureTech Health LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 07/25/2023 |
SC 13E3
| Form SC 13E3 - Going private transaction by certain issuers: |
| 06/29/2023 |
SC 13D/A
| PureTech Health LLC has filed a Schedule 13D for Gelesis Holdings, Inc. |
| 05/31/2023 |
4
| PureTech Health plc (10% Owner) has filed a Form 4 on GELESIS HOLDINGS, INC.|
Txns:
| Bought convertible notes
@ $0.0142, valued at
$0
Bought 43,133,803 warrants
@ $0.0142, valued at
$612.5k
|
|
| 05/30/2023 |
SC 13D/A
| PureTech Health LLC reports a 88.4% stake in Gelesis Holdings, Inc. |
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2023 |
SC 13D/A
| PureTech Health LLC reports a 87% stake in Gelesis Holdings, Inc. |
| 04/20/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/04/2023 |
SC 13D/A
| PureTech Health LLC has filed a Schedule 13D for Gelesis Holdings, Inc. |
| 02/23/2023 |
SC 13D/A
| PureTech Health LLC has filed a Schedule 13D for Gelesis Holdings, Inc. |
| 08/29/2022 |
3
| PureTech Health plc (10% Owner) has filed a Form 3 on Akili, Inc. |
| 08/12/2022 |
SC 13D/A
| PureTech Health LLC reports a 4.6% stake in Karuna Therapeutics, Inc. |
| 08/09/2022 |
SC 13D/A
| PureTech Health LLC reports a 5.1% stake in Karuna Therapeutics, Inc. |
| 08/04/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/21/2022 |
SC 13D
| PureTech Health LLC reports a 23.6% stake in Gelesis Holdings, Inc. |
| 01/21/2022 |
3
| PureTech Health plc (10% Owner) has filed a Form 3 on GELESIS HOLDINGS, INC. |
| 11/12/2021 |
SC 13D/A
| PureTech Health LLC reports a 5.6% stake in Karuna Therapeutics, Inc. |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/26/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2020 |
SC 13D/A
| PureTech Health LLC reports a 18.1% stake in Karuna Therapeutics, Inc. |
| 05/26/2020 |
4
| PureTech Health LLC (10% Owner) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 550,000 shares
@ $81, valued at
$44.6M
Sold 5,500 shares
@ $84.5, valued at
$464.8k
|
|
| 05/05/2020 |
SC 13D/A
| PureTech Health LLC reports a 0% stake in resTORbio, Inc. |
| 01/24/2020 |
4
| PureTech Health LLC (10% Owner) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Sold 2,100,000 shares
@ $95.67, valued at
$200.9M
|
|
| 12/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/19/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/17/2019 |
4
| PureTech Health LLC (10% Owner) has filed a Form 4 on resTORbio, Inc.|
Txns:
| Sold 205,763 shares
@ $1.2432, valued at
$255.8k
|
|
| 12/12/2019 |
4
| PureTech Health LLC (10% Owner) has filed a Form 4 on resTORbio, Inc.|
Txns:
| Sold 336,561 shares
@ $1.2588, valued at
$423.7k
Sold 59,921 shares
@ $1.25, valued at
$74.9k
Sold 385,884 shares
@ $1.2499, valued at
$482.3k
|
|
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2019 |
SC 13D
| PureTech Health LLC reports a 31.6% stake in Karuna Therapeutics, Inc. |
| 07/02/2019 |
4
| PureTech Health LLC (10% Owner) has filed a Form 4 on Karuna Therapeutics, Inc.|
Txns:
| Converted 5,194,800 shares
@ $0
Converted 1,751,704 shares
@ $0
Converted 428,895 shares
@ $0
Converted 4,000,000 options to buy
@ $0
Converted 1,348,814 preferred shares
@ $0
Converted 330,250 preferred shares
@ $0 |
|
| 06/27/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/09/2018 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
|
|
|